0001213900-15-007433.txt : 20151002 0001213900-15-007433.hdr.sgml : 20151002 20151002160725 ACCESSION NUMBER: 0001213900-15-007433 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151002 DATE AS OF CHANGE: 20151002 EFFECTIVENESS DATE: 20151002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Can-Fite BioPharma Ltd. CENTRAL INDEX KEY: 0001536196 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-248685 FILM NUMBER: 151140345 BUSINESS ADDRESS: STREET 1: 10 BAREKET STREET, KIRYAT MATALON STREET 2: P.O. BOX 7537 CITY: PETACH TIKVA STATE: L3 ZIP: 4951778 BUSINESS PHONE: 972 39241114 MAIL ADDRESS: STREET 1: 10 BAREKET STREET, KIRYAT MATALON STREET 2: P.O. BOX 7537 CITY: PETACH TIKVA STATE: L3 ZIP: 4951778 D 1 primary_doc.xml X0707 D LIVE 0001536196 Can-Fite BioPharma Ltd. 10 BAREKET STREET, KIRYAT MATALON PETACH TIKVA L3 ISRAEL 4951778 972 39241114 ISRAEL None None Corporation true Ilan Cohn 10 Bareket Street, Kiryat Matalon PO Box 7537 Petach Tikva L3 ISRAEL 4951778 Director Pnina Fishman 10 Bareket Street, Kiryat Matalon PO Box 7537 Petach Tikva L3 ISRAEL 4951778 Executive Officer Director Motti Farbstein 10 Bareket Street, Kiryat Matalon PO Box 7537 Petach Tikva L3 ISRAEL 4951778 Executive Officer Director Guy Regev 10 Bareket Street, Kiryat Matalon PO Box 7537 Petach Tikva L3 ISRAEL 4951778 Director Abraham Sartini 10 Bareket Street, Kiryat Matalon PO Box 7537 Petach Tikva L3 ISRAEL 4951778 Director Israel Shamay 10 Bareket Street, Kiryat Matalon PO Box 7537 Petach Tikva L3 ISRAEL 4951778 Director Gil Oren 10 Bareket Street, Kiryat Matalon PO Box 7537 Petach Tikva L3 ISRAEL 49517778 Director Pharmaceuticals Decline to Disclose 06b false 2015-09-21 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 4TH FLOOR NEW YORK NY NEW YORK 10022 IL ILLINOIS NJ NEW JERSEY false 9000002 9000002 0 The warrants and shares underlying the warrants, the subject matter of this Form D were issued in connection with an offering of (i) 2,068,966 ADSs issued in a registered direct offering, and (ii) unregistered warrants to purchase 1,034,483 ADSs. false 3 540000 0 HC Wainwright is also entitled to non-accountable expense reimbursement of $50,000 and H.C. Wainwright is entitled to warrants to purchase an aggregate of 103,448 ADSs exercisable at $5.25 per ADS for five years. 0 Issuer expects to use proceeds from the offering for working capital purposes which includes payment of salaries to the named executive officers false Can-Fite BioPharma Ltd. /Motti Farbstein/ Motti Farbstein Chief Operating and Financial Officer 2015-10-02